Stage IIIA endometrial carcinoma

Obstetrics and Gynecology

Volumn 114, Issue 1, 2009, Pages 100-105

  Bansal, Sharmilee ^a   Buck, Adam M ^a   Herzog, Thomas J ^b   Deutsch, Israel ^b   Burke, William M ^a   Wright, Jason D ^a,b  

^a Division of Gynecologic Oncology   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; KAPLAN MEIER METHOD; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; METASTASIS; MORTALITY; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; TREATMENT OUTCOME; VAGINA;

ADULT; AGED; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PELVIC NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 67651031031     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181a94568     Document Type: Article

References (22)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Mariani A, Webb MJ, Keeney GL, Aletti G, Podratz KC. Assessment of prognostic factors in stage IIIA endometrial cancer. Gynecol Oncol 2002;86:38-44.
3. Havrilesky LJ, Cragun JM, Calingaert B, Alvarez Secord A, Valea FA, Clarke-Pearson DL, et al. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer. Gynecol Oncol 2007;104:401-5.
4. Preyer O, Obermair A, Formann E, Schmid W, Perrin LC, Ward BG, et al. The impact of positive peritoneal washings and serosal and adnexal involvement on survival in patients with stage IIIA uterine cancer. Gynecol Oncol 2002;86:269-73.
5. Slomovitz BM, Ramondetta LM, Lee CM, Oh JC, Eifel PJ, Jhingran A, et al. Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapy. Int J Gynecol Cancer 2005;15:510-6.
6. Saga Y, Imai M, Jobo T, Kuramoto H, Takahashi K, Konno R, et al. Is peritoneal cytology a prognostic factor of endometrial cancer confined to the uterus? Gynecol Oncol 2006;103:277-80.
7. Grimshaw RN, Tupper WC, Fraser RC, Tompkins MG, Jeffrey JF. Prognostic value of peritoneal cytology in endome-trial carcinoma. Gynecol Oncol 1990;36:97-100.
8. Ebina Y, Hareyama H, Sakuragh N, Yamamoto R, Furuya M, Sogame M, et al. Peritoneal cytology and its prognostic value in endometrial carcinoma. Int Surg 1997;82:244-8.
9. Tebeu PM, Popowski GY, Verkooijen HM, Casals J, Ludicke F, Zeciri G, et al. Impact of peritoneal cytology on survival of endometrial cancer patients treated with surgery and radiotherapy. Br J Cancer 2003;89:2023-6.
10. Fadare O, Mariappan MR, Hileeto D, Wang S, McAlpine JN, Rimm DL. Upstaging based solely on positive peritoneal washing does not affect outcome in endometrial cancer. Mod Pathol 2005;18:673-80.
11. Dede M, Yenen MC, Goktolga U, Duru NK, Guden M, Dilek S, et al. Is adjuvant therapy necessary for peritoneal cytology-positive surgical-pathologic Stage I endometrial cancer? Preliminary results. Eur J Gynaecol Oncol 2004;25:591-3.
12. Turner DA, Gershenson DM, Atkinson N, Sneige N, Wharton AT. The prognostic significance of peritoneal cytology for stage I endometrial cancer. Obstet Gynecol 1989;74:775-80.
13. Obermair A, Geramou M, Tripcony L, Nicklin JL, Perrin L, Crandon AJ. Peritoneal cytology: impact on disease-free survival in clinical stage I endometrioid adenocarcinoma of the uterus. Cancer Lett 2001;164:105-10.
14. Lee CM, Slomovitz BM, Greer M, Sharma S, Gregurich MA, Burke T, et al. Practice patterns of SGO members for stage IIIA endometrial cancer. Gynecol Oncol 2005;98:77-83.
15. National Cancer Institute. Surveillance, Epidemiology, and End Results. SEER*Stat Database: Incidence-SEER 9 Regs Limited-Use, Nov 2006 Sub (1973-2004), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2007, based on the November 2006 submission. Available at: http://seer.cancer.gov. Retrieved October DD, 2007.
16. National Cancer Institute. Surveillance, Epidemiology, and End Results. Overview of the SEER program. Available at: http://seer.cancer.gov/about/. Retrieved October DD, 2007.
17. Frey CM, McMillen MM, Cowan CD, Horm JW, Kessler LG. Representativeness of the surveillance, epidemiology, and end results program data: recent trends in cancer mortality rates. J Natl Cancer Inst 1992;84:872-7.
18. The Comprehensive R Archive Network. Available at: http:// cran.r-project.org. Retrieved June 1, 2008.
19. Tebeu PM, Popowski Y, Verkooijen HM, Bouchardy C, Ludicke F, Usel M, et al. Positive peritoneal cytology in early-stage endometrial cancer does not influence prognosis. BrJ Cancer 2004;91:720-4.
20. Takeshima N, Nishida H, Tabata T, Hirai Y, Hasumi K. Positive peritoneal cytology in endometrial cancer: enhancement of other prognostic indicators. Gynecol Oncol 2001;82:470-3.
21. Kasamatsu T, Onda T, Katsumata N, Sawada M, Yamada T, Tsunematsu R, et al. Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus. Br J Cancer 2003;88:245-50.
22. Denschlag D, Tan L, Patel S, Kerim-Dikeni A, Souhami L, Gilbert L. Stage III endometrial cancer: preoperative predictability, prognostic factors, and treatment outcome. Am J Obstet Gynecol 2007;196:546.e1-7.